ChemoCentryx $69M Securities Class Action Settlement
Investors who purchased ChemoCentryx Inc. common stock between November 26, 2019, and May 6, 2021, may be eligible for a cash payment from a $69 million securities class action settlement. The lawsuit alleged that ChemoCentryx and its former CEO made material misrepresentations regarding the …